In contrast, Leung et al. [23] in their study of 127 colon cancer patients using TMA sections, did not find any significant association between the expression of EGFR, and patient outcome, but found HER-3 expression to be a significant predictor of survival outcome. This evidence concerns the gene ERBB3 and malignant colon neoplasm.